Sree Rayalaseema Hi-Strength Hypo Past Earnings Performance
Past criteria checks 4/6
Sree Rayalaseema Hi-Strength Hypo has been growing earnings at an average annual rate of 35.4%, while the Chemicals industry saw earnings growing at 16.8% annually. Revenues have been growing at an average rate of 18.3% per year. Sree Rayalaseema Hi-Strength Hypo's return on equity is 15.9%, and it has net margins of 11.5%.
Key information
35.4%
Earnings growth rate
35.5%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 18.3% |
| Return on equity | 15.9% |
| Net Margin | 11.5% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sree Rayalaseema Hi-Strength Hypo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 11,361 | 1,305 | 429 | 0 |
| 30 Sep 23 | 12,224 | 1,374 | 401 | 0 |
| 30 Jun 23 | 13,411 | 1,426 | 390 | 0 |
| 31 Mar 23 | 16,501 | 1,543 | 392 | 0 |
| 31 Dec 22 | 16,290 | 1,205 | 323 | 0 |
| 30 Sep 22 | 16,233 | 1,235 | 351 | 0 |
| 30 Jun 22 | 15,503 | 1,205 | 334 | 0 |
| 31 Mar 22 | 12,673 | 1,028 | 307 | 0 |
| 31 Dec 21 | 11,590 | 790 | 311 | 0 |
| 30 Sep 21 | 10,708 | 697 | 262 | 0 |
| 30 Jun 21 | 10,028 | 652 | 251 | 0 |
| 31 Mar 21 | 9,108 | 606 | 259 | 0 |
| 31 Dec 20 | 7,846 | 584 | 236 | 0 |
| 30 Sep 20 | 7,508 | 516 | 232 | 0 |
| 30 Jun 20 | 7,096 | 436 | 226 | 0 |
| 31 Mar 20 | 6,891 | 379 | 232 | 0 |
| 31 Dec 19 | 7,063 | 192 | 289 | 0 |
| 30 Sep 19 | 6,971 | 187 | 290 | 0 |
| 30 Jun 19 | 7,087 | 224 | 215 | 0 |
| 31 Mar 19 | 7,021 | 204 | 287 | 0 |
| 31 Dec 18 | 6,820 | 528 | 249 | 0 |
| 30 Sep 18 | 6,518 | 441 | 236 | 0 |
| 30 Jun 18 | 5,994 | 376 | 229 | 0 |
| 31 Mar 18 | 5,461 | 366 | 214 | 0 |
| 31 Dec 17 | 2,639 | 97 | 51 | 0 |
| 30 Sep 17 | 2,109 | 104 | 54 | 0 |
| 30 Jun 17 | 1,887 | 107 | 56 | 0 |
| 31 Mar 17 | 1,643 | 87 | 54 | 0 |
| 31 Dec 16 | 3,797 | 196 | 156 | 0 |
| 30 Sep 16 | 3,941 | 248 | 147 | 0 |
| 30 Jun 16 | 3,688 | 236 | 137 | 0 |
| 31 Mar 16 | 3,635 | 250 | 138 | 0 |
| 31 Dec 15 | 3,587 | 210 | 689 | 0 |
| 30 Sep 15 | 3,650 | 172 | 688 | 0 |
| 30 Jun 15 | 2,260 | 193 | 45 | 0 |
| 31 Mar 15 | 3,924 | 194 | 681 | 0 |
| 31 Dec 14 | 3,850 | 155 | 539 | 0 |
| 30 Sep 14 | 3,585 | 144 | 532 | 0 |
| 30 Jun 14 | 4,871 | 111 | 195 | 0 |
| 31 Mar 14 | 2,967 | 74 | 520 | 0 |
| 31 Dec 13 | 2,900 | 25 | 539 | 0 |
| 30 Sep 13 | 2,954 | 27 | 531 | 0 |
| 30 Jun 13 | 2,979 | 69 | 541 | 0 |
Quality Earnings: 532842 has high quality earnings.
Growing Profit Margin: 532842's current net profit margins (11.5%) are higher than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 532842's earnings have grown significantly by 35.4% per year over the past 5 years.
Accelerating Growth: 532842's earnings growth over the past year (8.3%) is below its 5-year average (35.4% per year).
Earnings vs Industry: 532842 earnings growth over the past year (8.3%) exceeded the Chemicals industry -4.7%.
Return on Equity
High ROE: 532842's Return on Equity (15.9%) is considered low.